Durable Disease Control with Local Treatment for Oligoprogression of Metastatic Solid Tumors Treated with Immune Checkpoint Blockade

被引:0
|
作者
Sindhu, K. [1 ]
Leiter, A. [2 ]
Carroll, E. [3 ]
Brooks, D. [3 ]
Ben Shimol, J. [4 ]
Eisenberg, E. [3 ]
Gallagher, E. J. [2 ,5 ]
Stock, R. G. [1 ]
Galsky, M. [5 ,6 ]
Buckstein, M. [1 ]
机构
[1] Icahn Sch Med Mt Sinai, Dept Radiat Oncol, New York, NY 10029 USA
[2] Icahn Sch Med Mt Sinai, Dept Med, Div Endocrinol, New York, NY 10029 USA
[3] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA
[4] Icahn Sch Med Mt Sinai, Dept Med, Div Rheumatol, New York, NY 10029 USA
[5] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[6] Icahn Sch Med Mt Sinai, Dept Med, Div Hematol & Med Oncol, New York, NY 10029 USA
关键词
D O I
10.1016/j.ijrobp.2019.06.1028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
3511
引用
收藏
页码:E650 / E650
页数:1
相关论文
共 50 条
  • [1] Oligoprogression of Solid Tumors on Immune Checkpoint Inhibitors: The Impact of Local Ablative Radiation Therapy
    Sindhu, Kunal K.
    Nehlsen, Anthony D.
    Lehrer, Eric J.
    Rowley, Jared P.
    Stock, Richard G.
    Galsky, Matthew D.
    Buckstein, Michael
    BIOMEDICINES, 2022, 10 (10)
  • [2] Efficacy of local ablative therapies in patients with solid tumors treated with immune checkpoint inhibitors and oligoprogression: a single-center analysis
    Ozluk, Ahmet Anil
    Karateke, Murat
    Sanli, Ulus Ali
    Karaca, Burcak
    MELANOMA RESEARCH, 2023, 33 (05) : 417 - 421
  • [3] Immune-checkpoint blockade — durable cancer control
    Elizabeth I. Buchbinder
    F. Stephen Hodi
    Nature Reviews Clinical Oncology, 2016, 13 : 77 - 78
  • [4] Immune-checkpoint blockade - durable cancer control
    Buchbinder, Elizabeth I.
    Hodi, F. Stephen
    NATURE REVIEWS CLINICAL ONCOLOGY, 2016, 13 (02) : 77 - 78
  • [5] Oligometastases and Oligoprogression: Evidence for local treatment in metastatic disease
    Andratschke, N.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S191 - S191
  • [7] Humanized mice for immune checkpoint blockade in human solid tumors
    Yip, Henry
    Haupt, Carl
    Maresh, Grace
    Zhang, Xin
    Li, Li
    AMERICAN JOURNAL OF CLINICAL AND EXPERIMENTAL UROLOGY, 2019, 7 (05): : 313 - 320
  • [8] Intrinsic Resistance of Solid Tumors to Immune Checkpoint Blockade Therapy
    Zhao, Xianda
    Subramanian, Subbaya
    CANCER RESEARCH, 2017, 77 (04) : 817 - 822
  • [9] Procedural interventions for oligoprogression during treatment with immune checkpoint blockade in gynecologic malignancies: a case series
    Sia, Tiffany Y.
    Wan, Vivian
    Finlan, Michael
    Zhou, Qin C.
    Iasonos, Alexia
    Zivanovic, Oliver
    Sonoda, Yukio
    Chi, Dennis S.
    Long Roche, Kara
    Jewell, Elizabeth
    Tew, William P.
    O'Cearbhaill, Roisin E.
    Cohen, Seth
    Makker, Vicky
    Liu, Ying L.
    Friedman, Claire F.
    Kyi, Chrisann
    Zamarin, Dmitriy
    Gardner, Ginger
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (04) : 594 - 601
  • [10] Durable response in a patient with recurrent respiratory papillomatosis treated with immune checkpoint blockade
    Bai, Ke
    Norberg, Scott M.
    Sievers, Cem
    Meyer, Tanya
    Friedman, Jay
    Hinrichs, Christian
    Allen, Clint T.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2022, 44 (10): : E31 - E37